Drug Pipeline

Lepodisiran Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Phase 3
1
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-20 NCT06916078
A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe…		 date change Primary completion pushed: 2026-06 -> 2026-08
2026-05-20 NCT06916078
A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe…		 date change Completion pushed: 2026-06 -> 2026-08
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-29 NCT07613294 A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With… Phase 3 Not Yet Recruiting
Active Studies by Phase
Phase 3
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06292013 A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse… Atherosclerotic Cardiovascular Disease (ASCVD) Active, Not Recruiting
NCT07613294 A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With… Atherosclerosis Not Yet Recruiting
Phase 1
NCT06916078 A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe… Liver Dysfunction Recruiting
Sponsors Running Lepodisiran Trials
Eli Lilly and Company (3)
Disease Areas
Heart Disease (2)
Get alerts when Lepodisiran trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free